ADAR and liver cancer: In this study, we investigated the oncogenic function of ADAR1 by promoting miR-3144-3p editing to simultaneously induce Musashi RNA-binding protein 2 (MSI2) and suppress solute carrier family 38 member 4 (SLC38A4) in human liver cancer.